IRIDEX CORP (IRIX) Stock News

NASDAQ:IRIX - US4626841013 - Common Stock

1.3 USD

+0.03 (+2.36%)

Last: 8/27/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

IRIX Latest News, Press Relases and Analysis

All

Press Releases

15 days ago - By: The Motley Fool

Iridex Reports 7 Percent Q2 Revenue Gain

16 days ago - By: IRIDEX Corporation

Iridex Reports Second Quarter 2025 Financial Results

16 days ago - By: IRIDEX Corporation

Iridex Reports Second Quarter 2025 Financial Results

a month ago - By: IRIDEX Corporation

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

a month ago - By: IRIDEX Corporation

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

5 months ago - By: Benzinga

Earnings Preview For Iridex

10 months ago - By: Benzinga - Mentions: SILV SKYX XTNT HNRG ...

Earnings Scheduled For November 12, 2024

2 months ago - By: IRIDEX Corporation

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

2 months ago - By: IRIDEX Corporation

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

4 months ago - By: IRIDEX Corporation

Iridex Reports First Quarter 2025 Financial Results

4 months ago - By: IRIDEX Corporation

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

5 months ago - By: IRIDEX Corporation

Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025

5 months ago - By: IRIDEX Corporation

Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025

5 months ago - By: IRIDEX Corporation

Iridex to Host Strategic Vision Call on April 16, 2025

5 months ago - By: IRIDEX Corporation

Iridex to Host Strategic Vision Call on April 16, 2025

5 months ago - By: IRIDEX Corporation

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

5 months ago - By: IRIDEX Corporation

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

5 months ago - By: IRIDEX Corporation

Iridex Announces Strategic Investment in the Company

5 months ago - By: IRIDEX Corporation

Iridex Announces Strategic Investment in the Company

6 months ago - By: IRIDEX Corporation

Iridex Comments on Recent Stock Price Volatility

6 months ago - By: IRIDEX Corporation

Iridex Comments on Recent Stock Price Volatility

6 months ago - By: IRIDEX Corporation

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

6 months ago - By: IRIDEX Corporation

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

8 months ago - By: IRIDEX Corporation

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024

8 months ago - By: IRIDEX Corporation

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024

8 months ago - By: IRIDEX Corporation

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

8 months ago - By: IRIDEX Corporation

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

9 months ago - By: IRIDEX Corporation

Iridex Comments on Changing Glaucoma Reimbursement Landscape

9 months ago - By: IRIDEX Corporation

Iridex Comments on Changing Glaucoma Reimbursement Landscape

10 months ago - By: IRIDEX Corporation

Iridex Reports Third Quarter 2024 Financial Results